Goldman Sachs Resumes Cephalon (CEPH) at Neutral
Tweet
Share
E-mailGet Alerts CEPH Hot Sheet
Price: $81.49 --0%
Rating Summary:
1 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 9 | New: 8
Rating Summary:
1 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 9 | New: 8
Join SI Premium – FREE
Goldman Sachs reinstated coverage on Cephalon (NASDAQ: CEPH) with a Neutral rating and $75 price target following the recent acquisition of the company by Teva.
For more ratings news on Cephalon click here and for the rating history of Cephalon click here.
Shares of Cephalon closed at $79.70 yesterday.
For more ratings news on Cephalon click here and for the rating history of Cephalon click here.
Shares of Cephalon closed at $79.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
- JPMorgan Starts Neway Valve Suzhou Co Ltd (603699:CH) at Overweight
- Alliance Global Partners Starts Momentus (MNTS) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
